Literature DB >> 15051647

Implantable cardioverter defibrillator in arrhythmogenic right ventricular cardiomyopathies.

Guy Fontaine1, Catherine Prost-Squarcioni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15051647     DOI： 10.1161/01.CIR.0000121322.91189.2E

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  Unusual cause of syncope in young girl: arrhythmogenic right ventricular cardiomyopathy.

Authors:  Marcus Mutschelknauss; Lucas Jörg; Florian Schmid; Hans Rickli; Peter Ammann
Journal:  Clin Res Cardiol       Date:  2010-01-05       Impact factor: 5.460

2.  The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).

Authors:  Kathy A Hodgkinson; Patrick S Parfrey; Anne S Bassett; Christine Kupprion; Jörg Drenckhahn; Mark W Norman; Ludwig Thierfelder; Susan N Stuckless; Elizabeth L Dicks; William J McKenna; Sean P Connors
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

3.  Focal macroscopic fat deposition within the right ventricular wall in asymptomatic patients undergoing screening EBCT coronary calcium scoring examinations.

Authors:  Jacobo Kirsch; Eric E Williamson; James F Glockner
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-01       Impact factor: 2.357
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.